Nikethamide

	WikiDoc Resources for Nikethamide
Articles
Most recent articles on Nikethamide Most cited articles on Nikethamide Review articles on Nikethamide Articles on Nikethamide in N Eng J Med, Lancet, BMJ
Media
Powerpoint slides on Nikethamide Images of Nikethamide Photos of Nikethamide Podcasts & MP3s on Nikethamide Videos on Nikethamide
Evidence Based Medicine
Cochrane Collaboration on Nikethamide Bandolier on Nikethamide TRIP on Nikethamide
Clinical Trials
Ongoing Trials on Nikethamide at Clinical Trials.gov Trial results on Nikethamide Clinical Trials on Nikethamide at Google
Guidelines / Policies / Govt
US National Guidelines Clearinghouse on Nikethamide NICE Guidance on Nikethamide NHS PRODIGY Guidance FDA on Nikethamide CDC on Nikethamide
Books
Books on Nikethamide
News
Nikethamide in the news Be alerted to news on Nikethamide News trends on Nikethamide
Commentary
Blogs on Nikethamide
Definitions
Definitions of Nikethamide
Patient Resources / Community
Patient resources on Nikethamide Discussion groups on Nikethamide Patient Handouts on Nikethamide Directions to Hospitals Treating Nikethamide Risk calculators and risk factors for Nikethamide
Healthcare Provider Resources
Symptoms of Nikethamide Causes & Risk Factors for Nikethamide Diagnostic studies for Nikethamide Treatment of Nikethamide
Continuing Medical Education (CME)
CME Programs on Nikethamide
International
Nikethamide en Espanol Nikethamide en Francais
Business
Nikethamide in the Marketplace Patents on Nikethamide
Experimental / Informatics
List of terms related to Nikethamide

Nikethamide
Clinical data
Synonyms	Nicotinic acid diethylamide
AHFS/Drugs.com	International Drug Names
ATC code	R07AB02 (WHO) ;
Pharmacokinetic data
Elimination half-life	0.5 h
Identifiers
	IUPAC name N,N-Diethyl-3-pyridinecarboxamide;
CAS Number	59-26-7 ;
PubChem CID	5497;
ChemSpider	5296 ;
UNII	368IVD6M32;
KEGG	D07408 ;
E number	{{#property:P628}}
ECHA InfoCard	{{#property:P2566}}Lua error in Module:EditAtWikidata at line 36: attempt to index field 'wikibase' (a nil value).
Chemical and physical data
Formula	C10H14N2O
Molar mass	178.231
3D model (JSmol)	Interactive image;
	SMILES O=C(N(CC)CC)c1cccnc1;
	InChI InChI=1S/C10H14N2O/c1-3-12(4-2)10(13)9-6-5-7-11-8-9/h5-8H,3-4H2,1-2H3 ; Key:NCYVXEGFNDZQCU-UHFFFAOYSA-N ;
(verify)

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]

Overview

Nikethamide is a stimulant which mainly affects the respiratory cycle. Widely known by its former trade name of Coramine, it was used in the mid-twentieth century as a medical countermeasure against tranquilizer overdoses, before the advent of endotracheal intubation and positive-pressure lung expansion. It is now considered to be of no value for such purposes, and may be dangerous.^[1]

In alternate terminology, it is known as nicotinic acid diethylamide, which meaningfully emphasizes its laboratory origins, and of which its common name is derived as a blend.

Former and current medical use

Coramine was used by suspected serial killer John Bodkin Adams when treating patient Gertrude Hullett, whom he was suspected of murdering.^[2] However, the toxicity of nikethamide is quite low (Template:LD50 rabbits 650 mg/Kg oral, LD₅₀ rats 240 mg/Kg s.c.).

Theodor Morell, Adolf Hitler's personal physician, would inject the German ruler with Coramine when Hitler was unduly sedated with barbiturates. In addition, Morell would use Coramine as part of an all-purpose "tonic" for Hitler.^[3]

It is available as a short-acting over-the-counter drug in several South American and European countries, combined with glucose in form of lozenges. It is especially useful for mountain climbers to increase endurance at high altitudes. Contraindications include hypertension, cardiovascular pathologies and epilepsy.^[4]

Use in sports

In some sports, nikethamide is listed by the World Anti-Doping Agency as a banned substance. Croatian tennis player Marin Čilić was suspended from competition for nine months after he tested positive for nikethamide in April 2013.^[5] This ban was later reduced to four months after Cilic appealed and claimed he had unintentionally ingested it in a glucose tablet bought at a pharmacy.^[6] Polish kart driver Igor Walilko was given a two-year ban, later reduced to eighteen month, from competition in 2010 due to testing positive for nikethamide after a win in Germany in July, 2010.^[7]

References

↑ Martindale, The Extra Pharmacopoeia, 30th ed, p1229
↑ Cullen, Pamela V., "A Stranger in Blood: The Case Files on Dr John Bodkin Adams", London, Elliott & Thompson, 2006, ISBN 1-904027-19-9
↑ Doyle D (February 2005). "Adolf Hitler's medical care" (PDF). J. R. Coll. Physicians Edinb. 35 (1): 75–82. ISSN 1478-2715. OCLC 49953788. PMID 15825245. Retrieved 2009-03-15.
↑ Nikethamid, III-3.3, Toxcenter
↑ "Marin Cilic: Croatian banned for nine months". BBC News. 16 September 2013. Retrieved 16 September 2013.
↑ "Cilic cleared to play again after suspension reduced". Tennis. 25 October 2013. Retrieved 25 October 2013.
↑ FIA Igor Walilko ruling

External links

Template:DiseasesDB

Template:Respiratory stimulants

[1] Martindale, The Extra Pharmacopoeia, 30th ed, p1229

[2] Cullen, Pamela V., "A Stranger in Blood: The Case Files on Dr John Bodkin Adams", London, Elliott & Thompson, 2006, ISBN 1-904027-19-9

[3] Doyle D (February 2005). "Adolf Hitler's medical care" (PDF). J. R. Coll. Physicians Edinb. 35 (1): 75–82. ISSN 1478-2715. OCLC 49953788. PMID 15825245. Retrieved 2009-03-15.

[4] Nikethamid, III-3.3, Toxcenter

[5] "Marin Cilic: Croatian banned for nine months". BBC News. 16 September 2013. Retrieved 16 September 2013.

[6] "Cilic cleared to play again after suspension reduced". Tennis. 25 October 2013. Retrieved 25 October 2013.

[7] FIA Igor Walilko ruling

[1]

[2]

[3]

[4]

[5]

[6]

[7]